rilparencel
·Code: NKA, REACT
rilparencel: developed by 1 company · 1 FDA decision. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| PROKIDNEY CORP. (PROK) | Phase 1 |
FDA Decisions
FDA_MeetingConfirmation of alignment with the U.S. Food and Drug Administration on the accelerated approval pathway for rilparencel.(PROK)
Frequently asked questions
Who is developing rilparencel?
rilparencel is being developed by PROKIDNEY CORP..
What is rilparencel's latest FDA decision?
The most recent tracked FDA decision for rilparencel is FDA_Meeting for Confirmation of alignment with the U.S. Food and Drug Administration on the accelerated approval pathway for rilparencel., dated July 15, 2025.
Get deeper analysis on rilparencel
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis